Ann: Bio-Gene Submits Two New International Patent Applications, page-9

Most of the announcements since listing have had the feel of keeping BGT relevant, rather than being required announcements, but it was to be expected due to:

PDS - Section 12 Additional Information:

In the event the Company achieves Listing, the Company will retain Henslow as exclusive corporate advisor with a monthly retainer fee of $10,000 payable for a period of 9 months (which may be extended for a further 6 months if agreed between the parties).

... Henslow justifying it's monthly retainer by dribbling something, anything to the market.